openPR Logo
Press release

Non-Steroidal Anti-Inflammatory Drugs Market Size, Insights, Growth Rate, Trends Analysis And Forecast To 2032 | Pfizer Inc., Johnson & Johnson Services Inc.

04-30-2025 11:17 AM CET | Health & Medicine

Press release from: CoherentMI

Non-Steroidal Anti-Inflammatory Drugs Market

Non-Steroidal Anti-Inflammatory Drugs Market

The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 25.84 Bn in 2025 and is expected to reach USD 38.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

The Non-Steroidal Anti-Inflammatory Drugs Market research report not only assists newly entered businesses but also assists businesses of all levels, shapes, scope, experience levels and sizes. This report also provides a way for key organizations to further expansion and business growth. Potential areas are spotted in this market research report for the business expansion. This research report reveals important insights into the market scenario to enable key players to take calculated decision making and also provides future products, joint ventures, marketing strategy, developments, mergers and acquisitions, marketing, promotions, revenue, import, export, CAGR values, the industry as a whole, and the particular competitors faced are also studied in the large-scale market.

The overall business goal can be accomplished through this Non-Steroidal Anti-Inflammatory Drugs Market study report as it consists of all the current happenings and major innovations of the marketplace. One of the major purposes of the market research report is to maximize the business growth opportunities. It also helps key players to turn the business into a successful business by increasing the profit level. The report also analyzes the different segments along with major geographies that have more market demand. The competition analysis is also a major part of the report.

Request a Sample Copy of this Report at: https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market/request-sample

Key Industry Players and In-Depth Analysis Report:

Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Sanofi
GSK plc

Global Non-Steroidal Anti-Inflammatory Drugs Market Segments:

By Indication

Arthritis
Migraine
Ophthalmic Diseases
Others

By Route of Administration

Oral
Parenteral

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
E-Commerce

Get the Sample Copy of the Research Report: https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market/request-sample

Research Objectives:

➥ Focuses on the key manufacturers, to define, pronounce and examine the value, sales volume, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
➥ To share comprehensive information about the key factors influencing the growth of the market (opportunities, drivers, growth potential, industry-specific challenges and risks).
➥ To analyze the market to individual future prospects, growth trends and their involvement in the total market.
➥ To analyze reasonable developments such as agreements, expansions new product launches, and acquisitions in the market.
➥ To deliberately profile the key players and systematically examine their growth strategies.

Non-Steroidal Anti-Inflammatory Drugs Market Report Answers the Following Questions:

☛ How much revenue will the Non-Steroidal Anti-Inflammatory Drugs market generate by the end of the forecast period?
☛ Which regions are currently contributing the maximum share of the overall Non-Steroidal Anti-Inflammatory Drugs market?
☛ What are the main strategies of the major players in the Non-Steroidal Anti-Inflammatory Drugs market to expand their geographic presence?
☛ What are the key products or services offered in the market, and how do they compare to each other?
☛ What are the current trends and factors driving the market? What challenges and opportunities exist?
☛ Which businesses, with the help of foreign companies, mergers and acquisitions, new product launches, and technical innovation, are possible to prosper within the international market?

Reason to Purchase this report:

✔️ This research report studies in detail the capital-intensive sectors playing an important role in the industry's economic development.
✔️ This report also provides an in-depth exploration of the trends, challenges, and opportunities within this dynamic market landscape. From enabling technological advancements to driving innovation and sustainability initiatives, the Non-Steroidal Anti-Inflammatory Drugs market plays a pivotal role in shaping the modern world economy.
✔️ The market size estimates, current market sizes, and market share analysis are also highlighted in this report.
✔️ Non-Steroidal Anti-Inflammatory Drugs report findings are devoted to analyse the change taking place in the industry in developed and developing countries.
✔️ The factors that have played an influential role in the GPP growth rate of the industry are highlighted in the report.

Access the full report and power your strategy: https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market/buynow

Table of Contents:

☑️ Market Summary
☑️ Economic Impact Competition Analysis by Players
☑️ Production, Revenue (Value) by geographical segmentation
☑️ Non-Steroidal Anti-Inflammatory Drugs Market Size by Type and Application
☑️ Regional Market Status and Outlook
☑️ Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Outlook
☑️ Market Forecast by Region, Type, and Application
☑️ Cost Investigation, Market Dynamics
☑️ Marketing Strategy comprehension, Distributors and Traders
☑️ Market Effect Factor Analysis
☑️ Research Finding/ Conclusion
☑️ Appendix

Author of this Marketing PR:

Vaagisha brings over three years of expertise as a PR writer in the market research domain. Originally a creative writer, she discovered her passion for writing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

📞 Contact Us:
Mr. Shah
CoherentMI,
U.S.: +1-650-918-5898
U.K: +44-020-8133-4027
Australia: +61-2-4786-0457
INDIA: +91-848-285-0837
Email: sales@coherentmi.com
Website: https://www.coherentmi.com

About CoherentMI:
At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Steroidal Anti-Inflammatory Drugs Market Size, Insights, Growth Rate, Trends Analysis And Forecast To 2032 | Pfizer Inc., Johnson & Johnson Services Inc. here

News-ID: 3994371 • Views:

More Releases from CoherentMI

How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 - Growth, Segments, and Revenue Trends| Otsuka Pharmaceutical, Reata Pharmaceuticals
How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 …
The latest report on the "Autosomal Dominant Polycystic Kidney Disease Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts, and Emerging Frontiers |Nicox, Qlaris Bio, TheratOcular Biotek Co.Ltd.
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts …
The latest report on the "Ocular Hypertension Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors such
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportunities, and Key Trends |Epizyme, Eli Lilly and Company, Pfizer, Merck Sharp & Dohme
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportun …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Epithelioid Sarcoma Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and Growth Through 2032 |Genentech, GlaxoSmithKline, Clovis Oncology, AstraZeneca
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and …
The latest report on the "Clear Cell Ovarian Cancer Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$